What Zevra Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 13 |
| Total trades | 5 | 28 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 62,300 | 706,200 |
| Disposed | 74,966 | 292,693 |
| Net activity | −12,666 | +413,507 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| McFarlane Neil F. | President and CEO | Oct 12 | Open-market sale · S | −20,000 | $11.25 | −$225K | 417,225 |
| McFarlane Neil F. | President and CEO | Oct 10 | Exercise / conversion · M | +50,000 | — | — | 437,225 |
| Thompson Rahsaan | Chief Legal & Compliance | Aug 14 | Open-market sale · S | −42,666 | $11.13 | −$475K | 37,569 |
| Watton Corey Michael | Director | Aug 10 | Open-market sale · S | −12,300 | $11.25 | −$138K | 1,800 |
| Watton Corey Michael | Director | Aug 10 | Exercise / conversion · M | +12,300 | $4.97 | +$61.1K | 14,100 |
| Thompson Rahsaan | Chief Legal & Compliance | Jun 22 | Open-market sale · S | −34,557 | $12.68 | −$438K | 80,235 |
| Thompson Rahsaan | Chief Legal & Compliance | Jun 21 | Exercise / conversion · M | +66,667 | — | — | 114,792 |
| Thompson Rahsaan | Chief Legal & Compliance | May 11 | Open-market sale · S | −1,794 | $11.30 | −$20.3K | 48,125 |
| Bode John B | Director | Mar 24 | Exercise / conversion · M | +39,200 | $4.89 | +$192K | 123,400 |
| Bode John B | Director | Mar 24 | Exercise / conversion · M | +39,200 | $4.97 | +$195K | 84,200 |
| McFarlane Neil F. | President and CEO | Feb 09 | Open-market sale · S | −14,625 | $8.56 | −$125K | 387,225 |
| McFarlane Neil F. | President and CEO | Feb 07 | Exercise / conversion · M | +37,500 | — | — | 401,850 |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Feb 03 | Open-market sale · S | −3,000 | $9.18 | −$27.5K | 29,590 |
| Schafer Joshua | CCO | Feb 03 | Open-market sale · S | −10,500 | $9.19 | −$96.5K | 62,278 |
| McFarlane Neil F. | President and CEO | Feb 02 | Open-market sale · S | −91,000 | $9.38 | −$853K | 364,350 |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Jan 31 | Exercise / conversion · M | +11,666 | — | — | 32,590 |
| McFarlane Neil F. | President and CEO | Jan 31 | Exercise / conversion · M | +233,334 | — | — | 455,350 |
| Schafer Joshua | CCO | Jan 31 | Exercise / conversion · M | +35,334 | — | — | 72,778 |
| Thompson Rahsaan | Chief Legal & Compliance | Jan 30 | Open-market sale · S | −4,080 | $8.83 | −$36K | 49,919 |
| Thompson Rahsaan | Chief Legal & Compliance | Jan 30 | Exercise / conversion · M | +11,333 | — | — | 53,999 |
Loading...
